Related content

Ovation Pharmaceuticals, Inc.

By Deutsch Barry  

Pharmacogenomics, Vol. 3, Iss. 6, 2002-11 ,pp. : 839-841

Future Medicine

Access to resources Recommend Favorite

Anadys Pharmaceuticals, Inc.

By Basbaum Andre  

Pharmacogenomics, Vol. 4, Iss. 4, 2003-07 ,pp. : 511-518

Future Medicine

Access to resources Recommend Favorite

Cequent Pharmaceuticals, Inc.: the biological pitcher for RNAi therapeutics

By Keates Andrew C   Fruehauf Johannes H   Xiang Shuanglin   Parker Peter D   Li Chiang J  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 867-871

Future Medicine

Access to resources Recommend Favorite

Iconix Pharmaceuticals, Inc. – removing barriers to efficient drug discovery through chemogenomics

By Engelberg Alan  

Pharmacogenomics, Vol. 5, Iss. 6, 2004-09 ,pp. : 741-744

Future Medicine

Access to resources Recommend Favorite

Millennium Pharmaceuticals

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. : 1605-1608

Informa Healthcare

Access to resources Recommend Favorite